GI/endoscopy company stock report – March 27, 2015

Here is a stock report on five publicly traded GI/endoscopy companies for March 23 to March 27.

Advertisement

•    AbbVie: $57.61 per share (up 0.63 percent)
•    Boston Scientific: $17.73 per share (up 1.66 percent)
•    FUJIFILM Holdings: 4,213.50 per share (JPY) (down 0.85 percent)
•    Olympus: 4,450 per share (JPY) (down 0.22 percent)
•    Salix Pharmaceuticals: $172.74 per share (up 0.06 percent)

More articles on gastroenterology:
Dr. Atif Iqbal: Using the LINX device for GERD treatment
6 reasons patients avoid undergoing screening colonoscopy
GI physician leader to know: Dr. Gary Gitnick of University of California, Los Angeles

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.